Stereotaxis (STXS) Net Cash Flow Growth (3y) (2013 - 2026)
Stereotaxis (STXS) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -55.30% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 39.87% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -159.90% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 78.59% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 36.49% |
| 10 | Stereotaxis | 128.56 Mn | 113.94 Mn | 3.79 Mn | 33.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.63% |
| Dec 31, 2025 | 28.65% |
| Sep 30, 2025 | 49.11% |
| Jun 30, 2025 | -28.83% |
| Mar 31, 2025 | 19.05% |
| Dec 31, 2024 | 37.36% |
| Sep 30, 2024 | -44.60% |
| Jun 30, 2024 | -335.38% |
| Mar 31, 2024 | -243.79% |
| Dec 31, 2023 | -108.17% |
| Sep 30, 2023 | -32.38% |
| Jun 30, 2023 | 2.26% |
| Mar 31, 2023 | -12.78% |
| Dec 31, 2022 | -148.65% |
| Sep 30, 2022 | -28.38% |
| Jun 30, 2022 | -44.88% |
| Mar 31, 2022 | -23.33% |
| Dec 31, 2021 | -45.87% |
| Sep 30, 2021 | -48.28% |
| Jun 30, 2021 | -53.50% |